Treatment with rivaroxaban compared with warfarin in patients with acute coronary syndrome
Phase 2
Recruiting
- Conditions
- Acute coronary syndrome.Other acute ischemic heart diseases
- Registration Number
- IRCT20210614051574N9
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 18 years
Acute coronary syndrome
Treated with aspirin and Plavix
Exclusion Criteria
Renal and hepatic failure
Existence of contraindications to anticoagulant therapy
Major trauma
Uncontrolled hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft ventricular morphology information. Timepoint: 3 months after starting the study. Method of measurement: Eco cardiography.;Bleeding. Timepoint: 3 months after starting the study. Method of measurement: Review the case and follow up with the patient.
- Secondary Outcome Measures
Name Time Method